Skip to main content

Research Repository

Advanced Search

Health economic evaluation of the cost effectiveness of antenatal screening for HPA-1 induced alloimmune thrombocytopenia (NAIT). (2003)
Presentation / Conference Contribution
Bessos, H., Turner, M., Fagge, T., Harkness, M., Rentoul, F., Seymour, J., Wilson, D., Gray, I., Ahya, R., Cairns, J., & Urbaniak, S. (2003, November). Health economic evaluation of the cost effectiveness of antenatal screening for HPA-1 induced alloimmune thrombocytopenia (NAIT). Presented at 56th Annual Meeting of the American Association of Blood Banks

Background: The great majority of severe NAIT is due to HPA-1a antibodies (ab). However, due to uncertainties in clinical management and health economics, HPA-1 phenotyping of pregnant women is not currently undertaken.
Aims of Study: The aims of th... Read More about Health economic evaluation of the cost effectiveness of antenatal screening for HPA-1 induced alloimmune thrombocytopenia (NAIT)..

Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial (2003)
Journal Article
Malcolm, C. A., McCulloch, D. L., Montgomery, C., Shepherd, A., & Weaver, L. T. (2003). Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Archives of disease in childhood. Fetal and neonatal edition, 88(5), 383F-390. https://doi.org/10.1136/fn.88.5.f383

Aim: To test the hypothesis that maternal docosahexaenoic acid (DHA) supplementation during pregnancy enhances maturation of the visual evoked potential (VEP) in healthy term infants.

Methods: One hundred women were supplemented with either fish... Read More about Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial.